Source | Code | Name | Case count | Share of cases (%) |
---|---|---|---|---|
PURCH | PURCH_ATC(L04AC10) | Secukinumab | 488 | |
PURCH | PURCH_ATC(L04AC05) | Ustekinumab | 447 | |
PURCH | PURCH_ATC(L04AC07) | Tocilizumab | 270 | |
PURCH | PURCH_ATC(L04AC13) | Ixekizumab | 231 | |
PURCH | PURCH_ATC(L04AC16) | Name not found | 157 | |
PURCH | PURCH_ATC(L04AC14) | Sarilumab | 95 | |
PURCH | PURCH_ATC(L04AC18) | Name not found | 59 | |
PURCH | PURCH_ATC(L04AC03) | Anakinra | 36 | |
PURCH | PURCH_ATC(L04AC) | Interleukin inhibitors | 26 | |
PURCH | PURCH_ATC(L04AC12) | Brodalumab | 6 |